
Glimilife M Forte 1 mg/1000 mg Tablet ER
Marketer
MSN Laboratories
Salt Composition
Glimepiride (1mg) + Metformin (1000mg)
Overview Glimilife M Forte 1 mg/1000 mg Tablet ER
Diabex Duo Forte, a 1 mg/1000 mg extended-release tablet, is an antidiabetic medication combining two active ingredients for adult type 2 diabetes management. This formulation helps regulate blood glucose. Diabex Duo Forte should be administered with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, increasing the risk of complications such as nephropathy, retinopathy, neuropathy, and limb loss. Remember, it's a component of a comprehensive diabetes management plan incorporating diet, exercise, and weight management as directed by your doctor. Lifestyle modifications significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, manifesting as sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential. Alcohol consumption should be minimized due to its hypoglycemic effect. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before initiating treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring and periodic blood tests to assess blood cell counts and liver function are recommended.
Uses of Glimilife M Forte 1 mg/1000 mg Tablet ER
Managing type 2 diabetes
Major Benefits of Glimilife M Forte 1 mg/1000 mg Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimilife M Forte 1 mg/1000 mg Extended-Release tablet whole; do not chew, crush, or divide it. Administer this medication with food.
Common Side effects of Glimilife M Forte 1 mg/1000 mg Tablet ER:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Glimilife M Forte 1 mg/1000 mg Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimilife M Forte 1 mg/1000 mg Extended-Release tablet whole; do not break, crush, or chew it. Administer this medication with a meal.
How Glimilife M Forte 1 mg/1000 mg Tablet ER works:
Glimilife M Forte (1 mg/1000 mg extended-release tablet) combines glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimilife M Forte 1 mg/1000 mg Tablet ER with alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The extended-release Glimilife M Forte 1 mg/1000 mg tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice.
Breast feedingUNSAFE
Extended-release Glimilife M Forte 1 mg/1000 mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Glimilife M Forte 1 mg/1000 mg Extended-Release tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of this medication. Regular monitoring of kidney function is recommended during treatment. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Glimilife M Forte 1 mg/1000 mg Extended-Release tablets cautiously, potentially requiring dosage modification. Consult a physician. For those with mild to moderate liver disease, initiation should be at a low dose; the medication is contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Glimilife M Forte 1 mg/1000 mg Tablet ER :
Should you forget a Glimilife M Forte 1 mg/1000 mg Extended-Release tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Glimilife M Forte 1 mg/1000 mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
